| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |